Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Healthtrust
Cipla
Deloitte
Harvard Business School
Boehringer Ingelheim
Colorcon
Cerilliant

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,641,800

« Back to Dashboard

Summary for Patent: 6,641,800
Title: Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
Abstract:Pressurized aerosol composition for administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers including recurring amide containing structural units, copolymers of amide containing units and carboxylic acid ester units, polyvinylacetate and acrylic acid/methacrylic acid ester copolymers.
Inventor(s): Mistry; Suresh N (Birstall, GB), Gibson; Mark (Shepshed, GB)
Assignee: Fisons Ltd. (West Malling, GB)
Application Number:09/616,069
Patent Claim Types:
see list of patent claims
Composition; Device; Process;

Drugs Protected by US Patent 6,641,800

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,641,800

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9120396Sep 25, 1991
United Kingdom9120675Sep 28, 1991
United Kingdom9124661Nov 19, 1991
United Kingdom9203212Feb 14, 1992

International Family Members for US Patent 6,641,800

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2119932 ➤ Try a Free Trial
China 1071832 ➤ Try a Free Trial
China 1050285 ➤ Try a Free Trial
Czech Republic 9400695 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Julphar
Teva
Express Scripts
Boehringer Ingelheim
Citi
Harvard Business School
Baxter
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.